Bioharvest Sciences (BHST) Capital Leases (2023 - 2025)

Bioharvest Sciences has reported Capital Leases over the past 3 years, most recently at $10.1 million for Q4 2025.

  • Quarterly results put Capital Leases at $10.1 million for Q4 2025, up 10.82% from a year ago — trailing twelve months through Dec 2025 was $10.1 million (up 10.82% YoY), and the annual figure for FY2025 was $10.1 million, up 10.82%.
  • Capital Leases for Q4 2025 was $10.1 million at Bioharvest Sciences, up from $9.1 million in the prior quarter.
  • Over the last five years, Capital Leases for BHST hit a ceiling of $10.1 million in Q4 2025 and a floor of $1.4 million in Q4 2023.
  • Median Capital Leases over the past 3 years was $9.1 million (2024), compared with a mean of $6.9 million.
  • Biggest five-year swings in Capital Leases: soared 541.47% in 2024 and later grew 10.82% in 2025.
  • Bioharvest Sciences' Capital Leases stood at $1.4 million in 2023, then soared by 541.47% to $9.1 million in 2024, then grew by 10.82% to $10.1 million in 2025.
  • The last three reported values for Capital Leases were $10.1 million (Q4 2025), $9.1 million (Q4 2024), and $1.4 million (Q4 2023) per Business Quant data.